WallStreetZenWallStreetZen

NASDAQ: MLYS
Mineralys Therapeutics Inc Stock Ownership - Who owns Mineralys Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Mineralys Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jon CongletonChief Executive Officer2025-11-2124,082$0.54
$13.00kBuy
Brian Taylor SlingsbyDirector2025-11-201,000,000$43.35
$43.35MSell
Alexander M. GoldDirector2025-11-1310,000$12.69
$126.90kBuy
Daphne KarydasDirector2025-11-134,885$46.36
$226.44kSell
Daphne KarydasDirector2025-11-1310,115$45.81
$463.35kSell
Alexander M. GoldDirector2025-11-1312,742$46.50
$592.50kSell
Alexander M. GoldDirector2025-11-132,742$10.20
$27.97kBuy
Daphne KarydasDirector2025-11-1315,000$10.20
$153.00kBuy
Alexander M. GoldDirector2025-11-121,933$47.28
$91.39kSell
Alexander M. GoldDirector2025-11-126,933$10.20
$70.72kBuy

1 of 8

MLYS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MLYS insiders and whales buy or sell their stock.

MLYS Shareholders

What type of owners hold Mineralys Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Srinivas Akkaraju14.33%11,338,067$421.10MInsider
Samsara Biocapital GP LLC13.58%10,749,832$399.25MInsider
Catalys Pacific LLC11.25%8,903,838$330.69MInstitution
Brian Taylor Slingsby9.99%7,903,838$293.55MInsider
Ra Capital Management LP9.25%7,323,750$272.00MInstitution
Samsara Biocapital LLC7.91%6,263,151$232.61MInstitution
Ra Capital Management LP4.72%3,734,458$138.70MInsider
Blackrock Inc4.64%3,671,614$136.36MInstitution
Hbm Healthcare Investments Cayman Ltd4.07%3,218,106$119.52MInsider
Vanguard Group Inc3.81%3,018,999$112.13MInstitution

1 of 3

MLYS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MLYS67.79%32.21%Net BuyingNet Selling
WVE74.84%25.16%Net BuyingNet Buying
CPRX84.02%15.82%Net SellingNet Selling
LQDA50.36%49.64%Net SellingNet Selling
DYN83.29%16.71%Net BuyingNet Selling
View Top Biotech Stocks

Mineralys Therapeutics Stock Ownership FAQ

Who owns Mineralys Therapeutics?

Mineralys Therapeutics (NASDAQ: MLYS) is owned by 100.25% institutional shareholders, 47.62% Mineralys Therapeutics insiders, and 0.00% retail investors. Srinivas Akkaraju is the largest individual Mineralys Therapeutics shareholder, owning 11.34M shares representing 14.33% of the company. Srinivas Akkaraju's Mineralys Therapeutics shares are currently valued at $421.10M.

If you're new to stock investing, here's how to buy Mineralys Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.